Deciphex

Deciphex is a medtech company founded in 2017 and based at Dublin City University’s Alpha campus in Ireland. The company specializes in AI-powered digital pathology, aiming to enhance diagnostic workflows and improve patient outcomes worldwide. With a team of around 200 employees, Deciphex operates a global network of AI-empowered pathologists, providing innovative pathology services that increase diagnostic precision and speed. Deciphex offers two main AI-driven platforms: Diagnexia and Patholytix. Diagnexia connects subspecialty pathologists to deliver rapid diagnostics and reduce backlogs, while Patholytix aids pharmaceutical companies in accelerating drug development through optimized preclinical safety assessments. The company collaborates with healthcare systems and pharmaceutical firms to address the global shortage of pathologists and improve healthcare efficiency by automating routine tasks, allowing pathologists to focus on more complex cases. Led by CEO Donal O’Shea, Deciphex is committed to transforming healthcare through its advanced technology and innovative solutions.

Information Technology & Services Dublin, Ireland ~28 employees Private · Series C

Work at Deciphex in HR or recruiting? Claim this page

Employees
28
0% in the 3 months to Jun 2025
Revenue / employee
$1.4M
Revenue ~$39.9M
Total funding
$67.2M
Last round Series C, Jan 2025
12-month attrition
34.7%
Tech: 45.8%
H1B filings, FY2025
2
Sponsors visas

Headcount trend

Deciphex went from 15 employees in Jul 2023 to 28 in Jun 2025. Jan to Jun 2025: 3 people joined, 0 left.

Headcount data through Jun 2025

Org structure

Headcount by department

Other10
Sales6
Operations5
Success4
Marketing2
Engineering1

H-1B sponsorship

H-1B Sponsorship Limited
H-1B Filings by Department
Marketing2

Funding

  • Jan 2025 · Series C · $32.1M · Molten Ventures, ACT Venture Capital, Seroba VC
  • Oct 2023 · Debt Financing · $10.5M · Claret Capital Partners
  • Jan 2023 · Series B · $4.2M · Seroba Life Sciences
  • May 2022 · Series B · $11.5M · ACT Venture Capital, Charles River Laboratories, Novartis AG
  • Jul 2020 · Series A · $6.2M · Irrus Investments, Halo Business Angel Network, Act Venture Capital Ltd.
  • Apr 2019 · Series A · $2.3M · Irrus Investments, ACT Venture Capital Limited, Inova Personalized Health Accelerator

Peer reviews

Worked with someone at Deciphex?

Anonymous peer reviews on OffTheRecord

Read or write a review

Similar companies

Deciphex FAQ

How many employees does Deciphex have?

Deciphex has about 28 employees, unchanged over the 3 months to Jun 2025.

Does Deciphex sponsor H1B visas?

Yes. Deciphex filed 2 H1B (LCA) applications in FY2025, according to the latest U.S. Department of Labor disclosures. Most of them were for Marketing roles.

What is Deciphex's revenue per employee?

Deciphex makes about $1.43M in revenue per employee, based on $39.9M annual revenue and 28 employees.

How much funding has Deciphex raised?

Deciphex has raised $67.16M in total funding; its latest round was Series C in Jan 2025.

Data from Company Prospectus, DOL LCA disclosures, WARN notices and 6figr salary profiles.